Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT04623580
Recruiting Observational

Flemish Inguinal and Femoral Hernia Prospective Registry

NCT04623580 · tracked via the Priya Life Science Belgium tracker
Sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Started
2018-01-01
Last updated
2024-07-01

Condition(s) studied

Inguinal Hernia

Investigational drug(s) / intervention(s)

Surgical inguinal or femoral hernia repair

Surgical inguinal or femoral hernia repair: Surgical inguinal or femoral hernia repair (primary or mesh)

Study summary

Prospective registry. The purpose of this clinical trial will be to measure surgical outcome parameters (e.g. recurrence, chronic pain and other quality indicators) after inguinal hernia repair using Patient Reported Outcome Measures (PROMs) in the short- and long-term.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria * Consecutively all patients with a groin hernia (inguinal and/or femoral hernia) operated starting 01.01.2018. * Male and female * 18 years or older * Operated of supervised by a participating surgeon (participating in this study is not necessarily by a whole surgical department of a hospital, but by specific surgeons) * Elective and emergency surgery * Primary and recurrent hernia * Metachronous and synchronous hernia * Signed informed consent form Exclusion criteria * Younger than 18 years * Not operated or supervised by participating surgeon * Pregnant at inclusion in the registry * No signed informed consent form

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
UZ Leuven Leuven Belgium Recruiting
Colette Barlé Leuven Belgium Recruiting

More Universitaire Ziekenhuizen KU Leuven trials in Belgium

Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis Active, not recruiting
Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids Recruiting
Continuous Glucose Monitoring for Women With Gestational Diabetes Recruiting
The Effect of Odors on Asthma Symptoms Enrolling by invitation
Ultrasound Features of Dupuytren's Disease Recruiting

Other trials for the same condition

Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair Recruiting
Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04623580 on ClinicalTrials.gov ↗ ← All trials in Belgium